IgVH Hypermutation Analysis Confirmatory Test
Introduction to the IgVH Hypermutation Analysis Confirmatory Test
The IgVH Hypermutation Analysis Confirmatory Test is a crucial diagnostic tool used in the evaluation and management of leukemia. This test analyzes the hypermutation status of the Immunoglobulin Heavy Chain Variable Region (IgVH) genes, providing valuable insights that can inform treatment decisions. With advancements in Next Generation Sequencing technology, this test enhances the accuracy of leukemia diagnostics, enabling healthcare providers to tailor treatment plans effectively.
What the Test Measures
This test specifically measures the mutation status of the IgVH genes. It detects whether the immunoglobulin genes have undergone hypermutation, which is an important factor in determining the prognosis and treatment options for patients with leukemia.
Who Should Consider This Test?
Individuals who may benefit from the IgVH Hypermutation Analysis Confirmatory Test include:
- Patients diagnosed with leukemia.
- Individuals exhibiting symptoms such as unexplained fatigue, frequent infections, or easy bruising.
- Those with risk factors, including a family history of hematological malignancies.
Benefits of Taking the Test
Taking the IgVH Hypermutation Analysis Confirmatory Test offers numerous benefits:
- Accurate diagnosis of leukemia subtypes.
- Informed treatment planning and management.
- Enhanced understanding of disease prognosis.
- Guidance for targeted therapies, improving patient outcomes.
Understanding Your Results
Results from the IgVH Hypermutation Analysis Confirmatory Test will indicate the mutation status of the IgVH genes. A positive hypermutation status may suggest a better response to certain treatments, while a negative status could indicate a need for more aggressive therapy. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 500000 NGN |
| Regular Price | 700000 NGN |
Booking the IgVH Hypermutation Analysis Confirmatory Test
To book the IgVH Hypermutation Analysis Confirmatory Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your appointment and answering any questions you may have.
Additional Information
Turnaround Time: Sample must be submitted by 11 am on Mondays; report available in 10 days.
Sample Type: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Pre-test Instructions: No special preparation required.
For more insights and to ensure proper diagnostic procedures, consult with a hematologist or oncologist.
